|
INSIDE THE CURRENT ISSUE |
October 2009 |
Products & Services |
New Technology |
New portable breath tester detects lung cancer
Scientists in Israel have devised a portable breath tester that
detects lung cancer with 86 percent accuracy, according to a study.
The device could provide an early warning system that flags the
disease before tumors become visible in X-rays, the researchers
reported in the journal Nature Nanotechnology.
The sensor uses gold nanoparticles to detect levels of so-called
volatile organic compounds (VOC) — measured in a few parts per billion
— that become more elevated in cancer patients. Early detection of
lung cancer dramatically increases the odds of survival. Currently,
only 15 percent of cases are discovered before the disease has begun
to spread. Screening via computerized tomography (CT) or chest x-rays
can reduce lung cancer deaths, but is expensive and exposes patients
to undesirable radiation.
In the study, a team of researchers lead by Hossam Haick of the
Israel Institute of Technology took breath samples from 56 healthy
people and 40 lung cancer patients.
To avoid contaminants, participants repeatedly filled their lungs
to capacity for five minutes through a filter that removed 99.99
percent of organic compounds from the air, a process called "lung
washout". Then the scientists hunted for VOCs present only in the
cancer patients that could serve as biomarkers for the disease. They
found 33 compounds that appeared in at least 83 percent of the cancer
group, but in fewer than 83 percent of the control group.
3M introduces first electronic stethoscope with wireless bluetooth
Taking the stethoscope into the 21st century, 3M announced the
introduction of the 3M Littmann Electronic Stethoscope Model 3200, a
next-generation auscultation device featuring Bluetooth technology
that wirelessly transfers heart, lung and other body sounds to
software for further analysis.
The company partnered with Connecticut-based Zargis Medical to
develop two companion software packages exclusively for the Littmann
Electronic Stethoscope Model 3200. Specifically: Zargis Cardioscan
software easily pairs with the Littmann Electronic Stethoscope Model
3200 to guide the clinician through four main cardiac sites, then
after approximately one minute, indicates whether or not the patient
possesses a suspected diastolic or systolic murmur—and whether or not
the murmur is suspected to be a Class I indication for
echocardiography referral.
Eighty-three percent of cardiologists reported that it was easier
to detect/hear an S3 gallop with a Littmann Electronic Stethoscope
Model 3000 Series. More information on the Littmann Electronic
Stethoscope 3000 Series, including a free 14-day
trial can be found at
www.Littmann.com.
|
|
Watching your hospital’s burgeoning waste line
Stericycle expands reach into strategic growth areas
by Rick Dana Barlow
C all what the medical waste management market
experienced during the last two decades as nothing less than a seismic shift
and you’d classify the momentum rather accurately.
Going back to the late 1980s and early 1990s, hospitals faced feverish
fallout for operating on-site incinerators with neighborhood protests
loosely organized under the "Not In My Backyard" or NIMBY banner.
In response, the federal government issued more stringent emissions
regulations that forced many hospitals to close their incinerators in favor
of alternative treatment and disposal methods and technologies, such as
autoclaving, electro-thermal deactivation (ETD) and microwaving. Treated
medical waste then could be hauled off-site. Or hospitals simply chose to
outsource treatment and disposal to companies offering those services.
Meanwhile, the competitive landscape among treatment and disposal
companies navigated through the same consolidation wave as the hospital and
healthcare supplier markets in the high-flying, healthcare reform-minded
mid-1990s. Chief among the big corporate moves at the time: The
fourth-largest solid waste management services company, Allied Waste
Industries Inc., agreed to acquire Browning-Ferris Industries Inc., the No.
2 player in the market that also served as the market leader in medical
waste treatment and disposal services.
But Allied, which adopted BFI’s more recognizable branding, wanted
nothing to do with the healthcare industry.
Enter Stericycle
Inc., a growing player in the healthcare market with its ETD technology,
that acquired the BFI division and ultimately crowned itself king of medical
waste management. It’s a title Stericycle still holds as it continues to
acquire other companies, the latest of which is privately held MedServ.
Amid the closing at press time, Healthcare Purchasing News Senior
Editor Rick Dana Barlow pitched a series of queries about industry trends to
Debra Gillmeister, Stericycle’s director of marketing for large quantity
healthcare services. With her clinical background, her experience as a
former advisory board member for the American Hospital Association’s
American Society for Healthcare Environmental Services and her MBA in
finance, Gillmeister fielded the questions with aplomb and authority.
HPN: Ten years ago, disposal methods seemed to dominate the debate
about managing medical waste. If you could encapsulate your impressions from
a 30,000-foot view, how has the industry changed in the last decade?
|
Debra Gillmeister |
|
GILLMEISTER:
There are several trends related to hospitals looking for
ways to be green. Green teams are forming in hospitals across the country.
From our experience, a significant percentage of hospitals have established
or are moving to initiate green programs that include clinical and
non-clinical members. Often these responsibilities start out as
supplementary, but more and more we are seeing dedicated full time ‘green’
staff. Leadership knows that it’s the right thing to do and is beginning to
acknowledge that these efforts enhance the hospital’s image in the
community. But it is challenging for hospitals to meet the Leadership in
Energy and Environmental Design (LEED) criteria. Only 73 healthcare
facilities of [American Hospital Association’s] nearly 5,000, or roughly 1.5
percent, have achieved LEED certification. Additional efforts to be green
include hospitals using reusable sharps containers, such as Bio Systems, and
finding ways to keep drugs out of the water. Essentially, we are seeing more
programs that protect the environment and benefit hospital staff, patients
and visitors.
Against the backdrop of "Not In My Backyard" or "NIMBY" protests back
then, the discussions simmered around autoclaving vs. incineration, with
alternative options like Stericycle’s electro-thermal deactivation (ETD)
technology inserted into the mix to compete with costly hauling services. In
your opinion, how far has the healthcare industry progressed or regressed
since that time and why?
[Environmental Protection Agency] regulations are designed to protect the
environment. Ten years ago, according to the EPA, there were 2,400 medical
waste incinerators in the U.S. with the goal to reduce this number by 50
percent to 80 percent by 2010. Much progress has been made towards that goal
with hundreds of on-site hospital incinerators being shut down. This is
because it is more difficult for a hospital to maintain this type of
investment and to meet additional regulations. Newly proposed EPA
regulations will make it harder to continue operating incinerators. Just
this year, we are aware of 11 Midwestern and Northeastern hospital
incinerators which have been or are pending shutdown. However, for certain
types of waste, incineration at a specialized dedicated facility is required
based on the regulations and state requirements.
How would you characterize Stericycle’s competitive landscape today,
compared to a decade ago?
Competition is ever-present in the business. With over 250 competitors
across the country and with the advent of greener offerings, more companies
are jumping on the bandwagon. This is why we have expanded our service
offerings to include not only our Sharps Management Service but our
Pharmaceutical Waste Compliance Service.
How do you move discussions about effective and efficient waste
management strategies beyond the seemingly endless debate over reusable vs.
disposable products?
Stericycle’s Sharps Management Service using Bio Systems reusable sharps
containers was introduced in 1986. By September 2009, more than 70 million
disposable containers have been kept out of landfills due to this service.
This is equal to more than 6 million gallons of gasoline not being burned
since the program started. Stericycle now offers tools like the Carbon
Footprint Estimator for hospitals to measure their diminished carbon
footprint. This tool is made available to any curious and conscientious
hospital that wants to become more aware of their carbon footprint. No
password is required for a hospital to use the tool. A Stericycle customer
measures their diminished environmental impact based on actual container
utilization, while a non-customer would obtain an estimate of what their
diminished footprint could be. For example, an average 200-bed acute care
hospital will divert more than 13,000 pounds of CO2 or equal to the emission
from 679 gallons of gasoline. Again, having green initiatives makes a
difference to staff, patients and the community.
(Editor’s Note: To access the Carbon Footprint Estimator, click on
http://www.stericycle.com/carbon-footprint-calculator.html.)
A few years ago, Stericycle was hopeful and optimistic that demand for
recycling and reuse would increase over time. Has that happened according to
expectations and market projections with the popular green movement?
We believe that the green movement is growing. From our perspective, by
keeping 70 million-plus reusable sharps containers out of landfills, a
significant positive impact on the environment has occurred. This is the
equivalent to preventing CO2 from going into the atmosphere that would be
generated by a 25-mpg car circling the earth 10 times.
While effective products for safely treating and disposing fluid medical
waste have been on the market for many years, the latest hot-button issue
centers on untreated pharmaceutical waste ending up in the water supply to
the extent that a growing number of hospitals are implanting drug waste
management programs. Given the long history of waste management debate over
solid, liquid and hazardous medical waste treatment and disposal, how did
the idea of drugs as a waste product fly under the radar for so long? Who,
if anyone, dropped the ball here?
We agree it is a complicated issue that has flown under the radar. [The
Resource Conservation and Recovery Act] has been around for 30-plus years
and was originally targeted to industrial and manufacturing processes. Until
pharmaceuticals started being detected in drinking water the issue was not
apparent, especially at the hospital level, even though best practices would
suggest that appropriate segregation and treatment of pharmaceutical waste
is required. Today, Stericycle has a solution for this issue. Our
Pharmaceutical Waste Compliance service offers a sustainable solution. Our
turn-key service categorizes a hospital formulary, trains staff to properly
segregate pharmaceutical waste and then insures that the waste is
appropriately transported and treated.
What kind of behavioral modification is needed for healthcare facilities
to treat and/or dispose of drugs as they would solid, liquid and hazardous
medical waste?
Training is critical and can be very complex. Stericycle’s national team
of healthcare compliance specialists train hospital staff over a
two-to-three day period. Included in this training is pharmacy, nursing,
nurse educators, environmental services, facilities and anyone who handles
pharmaceutical waste. Hospitals are slowly becoming aware and changing their
clinical practices because of RCRA, programs like Stericycle’s and state
legislation. For example, Illinois Gov. Pat Quinn recently signed several
key environmental bills including one that dictates that by Jan. 1, 2010,
healthcare institutions are prohibited from flushing or dumping unused
medications into public wastewater. The practice of disposing of
pharmaceuticals down the drain or in the toilet – excluding saline and
dextrose – whether hazardous or not, is not a clinical best practice.
What are the average costs to treat and dispose solid, liquid and
hazardous medical waste and how does the average cost to dispose of drug
waste compare to that?
Treating hazardous waste is more expensive due to the fact that only a
few incinerators across the country can handle this type of waste because of
the more stringent emission requirements. Each year more and more
regulations, especially at the state level, are being enacted that require
appropriate segregation, transportation and treatment of pharmaceutical
waste. This makes it more challenging to be compliant with the regulators.
However, if pharmaceutical waste is properly segregated only about 10
percent should be classified as hazardous. Proper classification and
segregation are two ways costs can be minimized.
Faced with a sour economy, tighter budgets and stiffer liabilities and
penalties, how does a healthcare facility realistically keep costs in check
to treat and dispose solid, liquid and hazardous medical waste, including
pharmaceuticals?
It is not so much the cost but the cost avoidance that is important to a
facility by maintaining best practices and having a waste segregation and
waste minimization program in place. Consider fines such as $37,500 per
violation per day that are levied by the EPA due to RCRA and $100,000 per
violation that is issued by the Department of Transportation. Negative press
regarding a violation can reflect on clinical practice and translate into
fewer patient admissions. Doctors have a choice of where to admit their
patients. Patients are becoming more educated consumers with regard to their
medical treatment.
Watching your hospital’s burgeoning waste line
Reprocessing fuels green strategies
|
|